Potential cost-effectiveness of early identification of hospital-acquired infection in critically ill patients

Annals of the American Thoracic Society

Volumn 13, Issue 3, 2016, Pages 401-413

  Tsalik, Ephraim L ^a,b,c   Li, Yanhong ^b   Hudson, Lori L ^b,c   Chu, Vivian H ^b   Himmel, Tiffany ^b   Limkakeng, Alex T ^c   Katz, Jason N ^d   Glickman, Seth W ^e   McClain, Micah T ^b,c,f   Welty Wolf, Karen E ^b,f   Fowler, Vance G ^b   Ginsburg, Geoffrey S ^b,c   Woods, Christopher W ^b,c,f   Reed, Shelby D ^b  

^a Emergency Medical Service   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Cost benefit analysis; Cross infection; Early diagnosis; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; PEPTIDE NUCLEIC ACID; PROCALCITONIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; COST EFFECTIVENESS ANALYSIS; CRITICALLY ILL PATIENT; DIAGNOSTIC TEST; FALSE NEGATIVE RESULT; FEMALE; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; INFECTION RATE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; THERAPY DELAY; VENTILATED PATIENT; VERY ELDERLY; CLINICAL TRIAL; COST BENEFIT ANALYSIS; CRITICAL ILLNESS; CROSS INFECTION; DECISION SUPPORT SYSTEM; EARLY DIAGNOSIS; ECONOMICS; MIDDLE AGED; MULTICENTER STUDY; NORTH CAROLINA; PNEUMONIA, VENTILATOR-ASSOCIATED; QUALITY ADJUSTED LIFE YEAR; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; CRITICAL ILLNESS; CROSS INFECTION; DECISION SUPPORT TECHNIQUES; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NORTH CAROLINA; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; QUALITY-ADJUSTED LIFE YEARS; YOUNG ADULT;

EID: 84989213492     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201504-205OC     Document Type: Article

References (48)

1. Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, Cardo DM. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122: 160-166.
2. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, et al.; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. Multistate pointprevalence survey of health care-associated infections. N Engl J Med 2014;370:1198-1208.
3. Anderson DJ, Kirkland KB, Kaye KS, Thacker PA II, Kanafani ZA, Auten G, Sexton DJ. Underresourced hospital infection control and prevention programs: penny wise, pound foolish? Infect Control Hosp Epidemiol 2007;28:767-773.
4. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005;33:2184-2193.
5. Warren DK, Shukla SJ, Olsen MA, Kollef MH, Hollenbeak CS, Cox MJ, Cohen MM, Fraser VJ. Outcome and attributable cost of ventilatorassociated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003;31:1312-1317.
6. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002;122:262-268.
7. Luna CM, Aruj P, Niederman MS, Garzón J, Violi D, Prignoni A, Ríos F, Baquero S, Gando S; Grupo Argentino de Estudio de la Neumońa Asociada al Respirador group. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J 2006;27: 158-164.
8. Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, Artigas A, Schorr C, Levy MM. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 2014;42:1749-1755.
9. Raman K, Nailor MD, Nicolau DP, Aslanzadeh J, Nadeau M, Kuti JL. Early antibiotic discontinuation in patients with clinically suspected ventilator-associated pneumonia and negative quantitative bronchoscopy cultures. Crit Care Med 2013;41:1656-1663.
10. Hranjec T, Rosenberger LH, Swenson B, Metzger R, Flohr TR, Politano AD, Riccio LM, Popovsky KA, Sawyer RG. Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis 2012;12:774-780.
11. Fournier PE, Drancourt M, Colson P, Rolain JM, La Scola B, Raoult D. Modern clinical microbiology: new challenges and solutions. Nat Rev Microbiol 2013;11:574-585.
12. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606-608.
13. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49:1-45.
14. Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Saint S, Schaeffer AJ, Tambayh PA, Tenke P, et al.; Infectious Diseases Society of America. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010;50:625-663.
15. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-455.
16. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
17. Klompas M, Branson R, Eichenwald EC, Greene LR, Howell MD, Lee G, Magill SS, Maragakis LL, Priebe GP, Speck K, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014;35:S133-S154.
18. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, et al.; EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323-2329.
19. Vazquez-Guillamet C, Scolari M, Zilberberg MD, Shorr AF, Micek ST, Kollef M. Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock. Crit Care Med 2014;42:2342-2349.
20. Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, Dodek P, Wood G, Kumar A, Simon D, et al.; Cooperative Antimicrobial Therapy of Septic Shock Database Research Group. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009;136:1237-1248.
21. Tsukamoto H, Higashi T, Nakamura T, Yano R, Hida Y, Muroi Y, Ikegaya S, Iwasaki H, Masada M. Clinical effect of a multidisciplinary team approach to the initial treatment of patients with hospitalacquired bloodstream infections at a Japanese university hospital. Am J Infect Control 2014;42:970-975.
22. Inchai J, Pothirat C, Liwsrisakun C, Deesomchok A, Kositsakulchai W, Chalermpanchai N. Ventilator-associated pneumonia: epidemiology and prognostic indicators of 30-day mortality. Jpn J Infect Dis 2015; 68:181-186.
23. Rosenthal VD, Bijie H, Maki DG, Mehta Y, Apisarnthanarak A, Medeiros EA, Leblebicioglu H, Fisher D, Álvarez-Moreno C, Khader IA, et al.; INICC members. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009. Am J Infect Control 2012;40:396-407.
24. Arias E. United States life tables, 2009. Natl Vital Stat Rep 2014;62: 1-63.
25. Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, Keohane C, Denham CR, Bates DW. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med 2013;173:2039-2046.
26. Kahn JM, Rubenfeld GD, Rohrbach J, Fuchs BD. Cost savings attributable to reductions in intensive care unit length of stay for mechanically ventilated patients. Med Care 2008;46:1226-1233.
27. Centers for Medicare and Medicaid Services. 2015 Clinical Diagnostic Laboratory Fee Schedule. Department of Health and Human Services. Baltimore, MD: CMS.gov; 2015 [Accessed 2015 Sep 22]. Available from: https://www.cms.gov/apps/ama/license.asp?file=/ClinicalLabFeeSched/Downloads/15CLAB.zip
28. Alexander BD, Ashley ED, Reller LB, Reed SD. Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. Diagn Microbiol Infect Dis 2006;54: 277-282.
29. Siegel JE, Torrance GW, Russell LB, Luce BR, Weinstein MC, Gold MR. Guidelines for pharmacoeconomic studies: recommendations from the panel on cost effectiveness in health and medicine. Panel on Cost Effectiveness in Health and Medicine. Pharmacoeconomics 1997;11:159-168.
30. Luangasanatip N, Hongsuwan M, Lubell Y, Limmathurotsakul D, Teparrukkul P, Chaowarat S, Day NP, Graves N, Cooper BS. Longterm survival after intensive care unit discharge in Thailand: a retrospective study. Crit Care 2013;17:R219.
31. Cuthbertson BH, Roughton S, Jenkinson D, Maclennan G, Vale L. Quality of life in the five years after intensive care: a cohort study. Crit Care 2010;14:R6.
32. Timmers TK, Verhofstad MH, Moons KG, Leenen LP. Long-term survival after surgical intensive care unit admission: fifty percent die within 10 years. Ann Surg 2011;253:151-157.
33. Ridley S, Plenderleith L. Survival after intensive care: comparison with a matched normal population as an indicator of effectiveness. Anaesthesia 1994;49:933-935.
34. Lehmann LE, Herpichboehm B, Kost GJ, Kollef MH, Stüber F. Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials. Crit Care 2010;14:R186.
35. Franz AR, Steinbach G, Kron M, Pohlandt F. Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and C-reactive protein as markers of bacterial infections. Pediatrics 1999; 104:447-453.
36. Anderson ST, Kaforou M, Brent AJ, Wright VJ, Banwell CM, Chagaluka G, Crampin AC, Dockrell HM, French N, Hamilton MS, et al.; ILULU Consortium; KIDS TB Study Group. Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl J Med 2014; 370:1712-1723.
37. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, Wilkinson KA, Banchereau R, Skinner J, Wilkinson RJ, et al. An interferoninducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010;466:973-977.
38. Kaforou M, Wright VJ, Oni T, French N, Anderson ST, Bangani N, Banwell CM, Brent AJ, Crampin AC, Dockrell HM, et al. Detection of tuberculosis in HIV-infected and-uninfected African adults using whole blood RNA expression signatures: a case-control study. Plos Med 2013;10:e1001538.
39. Scicluna BP, Klein Klouwenberg PMC, van Vught LA, Wiewel MA, Ong DSY, Zwinderman AH, Franitza M, Toliat MR, Nürnberg P, Hoogendijk AJ, et al. A molecular biomarker to diagnose communityacquired pneumonia on intensive care unit admission. Am J Respir Crit Care Med 2015;192:826-835.
40. Zaas AK, Burke T, Chen M, McClain M, Nicholson B, Veldman T, Tsalik EL, Fowler V, Rivers EP, Otero R, et al. A host-based RT-PCR gene expression signature to identify acute respiratory viral infection. Sci Transl Med 2013;5:203ra126.
41. Cobb JP, Moore EE, Hayden DL, Minei JP, Cuschieri J, Yang J, Li Q, Lin N, Brownstein BH, Hennessy L, et al. Validation of the riboleukogram to detect ventilator-associated pneumonia after severe injury. Ann Surg 2009;250:531-539.
42. Werner JA, Schierding W, Dixon D, MacMillan S, Oppedal D, Muenzer J, Cobb JP, Checchia PA. Preliminary evidence for leukocyte transcriptional signatures for pediatric ventilator-associated pneumonia. J Intensive Care Med 2012;27:362-369.
43. Warren HS, Elson CM, Hayden DL, Schoenfeld DA, Cobb JP, Maier RV, Moldawer LL, Moore EE, Harbrecht BG, Pelak K, et al.; Inflammation and Host Response to Injury Large Scale Collaborative Research Program. A genomic score prognostic of outcome in trauma patients. Mol Med 2009;15:220-227.
44. Johnson SB, Lissauer M, Bochicchio GV, Moore R, Cross AS, Scalea TM. Gene expression profiles differentiate between sterile SIRS and early sepsis. Ann Surg 2007;245:611-621.
45. Sweeney TE, Shidham A, Wong HR, Khatri P. A comprehensive timecourse-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci Transl Med 2015;7:287ra71.
46. Marston HD, Folkers GK, Morens DM, Fauci AS. Emerging viral diseases: confronting threats with new technologies. Sci Transl Med 2014;6:253ps10.
47. Klompas M. Interobserver variability in ventilator-associated pneumonia surveillance. Am J Infect Control 2010;38:237-239.
48. Stevens JP, Kachniarz B, Wright SB, Gillis J, Talmor D, Clardy P, Howell MD. When policy gets it right: variability in U.S. hospitals' diagnosis of ventilator-associated pneumonia. Crit Care Med 2014; 42:497-503.